Oncology & Cancer

Metabolic enzyme promotes neuroblastoma aggressiveness

High-risk neuroblastoma is an aggressive childhood cancer with poor treatment outcomes. Despite intensive chemotherapy and radiotherapy, less than 50 percent of these children survive for five years. While the genetics of ...